Ancillary Study to Protocol 20060104

Completed

• Conditions: Rheumatoid Arthritis
• Interventions: Procedure: Blood draw

• Registration Number: NCT00439894
• Lead Sponsor: Amgen

Brief Summary

Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-12
• Study First Submitted: 2007-02-22
• Study First Submitted QC: 2007-02-22
• Study First Posted: 2007-02-26
• Primary Completion: 2007-08
• Study Completion: 2007-10
• Status Verified: 2008-03
• Last Update Submitted: 2008-03-20
• Last Update Posted: 2008-03-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Signed informed Consent Meet all inclusion critieria outlined in Amgen Protocol 20060104

Exclusion Criteria

• Meet exclusion criteria outlined in Amgen Protocol 20060104

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
blood draw	Blood draw	One time blood draw

Primary Outcome Measures

Name	Time	Method
To explore the correlation between pheripheral blood cell protein phosphorylation assessemnts and rheumatoid arthritis disease activity.	week 24

Secondary Outcome Measures

Name	Time	Method
Explore the correlations to etanercept clinical response (ACR and DAS scores) may also be explored.	week 24